GlaxoSmithKline Sells Largest Polish Manufacturing Facility
GlaxoSmithKline Sells Largest Polish Manufacturing Facility
GALWAY, IRELAND--October 26, 2020--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--GlaxoSmithKline plc (LSE/NYSE: GSK) is to sell its largest Polish manufacturing facility to French contract development and manufacturing organization (CDMO) Delpharm for an undisclosed sum.
Within this article: Details plant sale, types of products produced, continuation of production for five years, related plant sales and job cuts in 2020
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- EU Adds New COVID-19 Manufacturing Capacity
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
